| # | Country | Total Patents | |
|---|---|---|---|
| #1 | China | 9 | |
| #2 | United States | 7 | |
| #3 | EPO (European Patent Office) | 5 | |
| #4 | Republic of Korea | 5 | |
| #5 | WIPO (World Intellectual Property Organization) | 5 | |
| #6 | Brazil | 3 | |
| #7 | Israel | 3 | |
| #8 | Taiwan | 3 | |
| #9 | Australia | 2 | |
| #10 | Japan | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology | |
| #4 | Foods and drinks | |
| #5 | Agriculture |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Microorganisms | |
| #3 | Medical preparations | |
| #4 | Peptides | |
| #5 | Climate change adaptation technologies | |
| #6 | Enzymes | |
| #7 | Animal care |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wu Chia-Mao | 22 |
| #2 | Chang Hsiu-Kang | 17 |
| #3 | Wu Jiun-Ming | 13 |
| #4 | Wu Chia Mao | 8 |
| #5 | Chiu Yi-Tsui | 8 |
| #6 | Wu Jiun Ming | 6 |
| #7 | Chang Hsiu Kang | 5 |
| #8 | Chou Wei-I | 5 |
| #9 | Lin Hsiang-Kai | 5 |
| #10 | Lin Yi-Chia | 5 |
| Publication | Filing date | Title |
|---|---|---|
| WO2019133647A1 | Combination of a fusion protein vaccine with anti-ox40 antibody for use in eliciting antigen-specific immune responses | |
| WO2018052854A1 | Hepatitis b therapeutic vaccines | |
| CN107249629A | Comprising immunogenic protein and combination adjuvant and to induce the vaccine combination that T cells with antigenic specificity reacts | |
| BR112015013135A2 | fusion proteins for use as immunogenic enhancers to induce antigen specific t cell responses |